Table 3.
Source | Type of feature | Count | Unique | Percent (%) |
---|---|---|---|---|
Drug Central83 | Molecular weight | 2,797 | 2,308 | 35.2 |
TPSA | 2,718 | 2,718 | 34.2 | |
cLogP | 2,574 | 980 | 32.3 | |
DrugBank80 | Group | 7,957 | 7,903 | 100.0 |
State | 6,517 | 6,463 | 81.9 | |
Category | 5,431 | 5,431 | 68.3 | |
Description | 4,591 | 4,565 | 57.7 | |
Indication | 3,393 | 3,076 | 42.6 | |
Mechanism of action | 3,242 | 3,161 | 40.7 | |
ATC 4 | 2,818 | 1,040 | 35.4 | |
ATC 3 | 2,818 | 2,818 | 35.4 | |
ATC 2 | 2,818 | 2,818 | 35.4 | |
ATC 1 | 2,818 | 2,818 | 35.4 | |
Pharmacodynamics | 2,659 | 2,617 | 33.4 | |
Half life | 2,063 | 1,893 | 25.9 | |
Protein binding | 1,669 | 1,487 | 21.0 | |
Pathway | 598 | 598 | 7.5 |
The count column refers to the number of features including duplicates, and the Unique column refers to the number of unique features.